Sundrug Co Ltd
TSE:9989
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
3 440
4 890
|
| Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Sundrug Co Ltd
Sundrug Co Ltd
Cost of Revenue
Sundrug Co Ltd
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Sundrug Co Ltd
TSE:9989
|
Cost of Revenue
-¥570.9B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-5%
|
|
|
Tsuruha Holdings Inc
TSE:3391
|
Cost of Revenue
-¥724.4B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-10%
|
|
|
Welcia Holdings Co Ltd
TSE:3141
|
Cost of Revenue
-¥862.9B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-13%
|
|
|
S
|
Sugi Holdings Co Ltd
TSE:7649
|
Cost of Revenue
-¥547B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-7%
|
|
|
MatsukiyoCocokara & Co
TSE:3088
|
Cost of Revenue
-¥674.9B
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-7%
|
|
|
Cosmos Pharmaceutical Corp
TSE:3349
|
Cost of Revenue
-¥789.3B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-10%
|
|
Sundrug Co Ltd
Glance View
Sundrug Co., Ltd. engages in the pharmaceutical business. The company is headquartered in Fuchu-Shi, Tokyo-To and currently employs 5,634 full-time employees. The Drug Store segment is primarily engaged in the sale of pharmaceutical products, cosmetic products and sundry goods, among others. The Discount Store segment is primarily engaged in the sale of foodstuffs, household sundry goods, among others.
See Also
What is Sundrug Co Ltd's Cost of Revenue?
Cost of Revenue
-570.9B
JPY
Based on the financial report for Jun 30, 2024, Sundrug Co Ltd's Cost of Revenue amounts to -570.9B JPY.
What is Sundrug Co Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-5%
Over the last year, the Cost of Revenue growth was -8%. The average annual Cost of Revenue growth rates for Sundrug Co Ltd have been -6% over the past three years , -5% over the past five years , and -5% over the past ten years .
You don't have any saved screeners yet
